Synthesis and pharmacological activity of acylated betulonic acid oxides and 28-Oxo-allobetulone

Pharmaceutical Chemistry Journal

Volumn 38, Issue 3, 2004, Pages 148-152

  Flekhter, O B ^a   Boreko, E I ^b   Nigmatullina, L R ^a   Pavlova, N I ^b   Medvedeva, N I ^a   Nikolaeva, S N ^b   Tret'yakova, E V ^a   Savinova, O V ^b   Baltina, L A ^a   Karachurina, L T ^a   Galin, F Z ^a   Zarudii, F S ^a   Tolstikov, G A ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^b Ministry of Health Republic of Belarus   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

28 OXO ALLOBETULONE 3 OXIME; 28 OXO ALLOBETULONE 3 OXIME ACETATE; 28 OXO ALLOBETULONE 3 OXIME HEMIPHTHALATE; 28 OXO ALLOBETULONE 3 OXIME HEMISUCCINATE; ACETYLSALICYLIC ACID; ANTIULCER AGENT; ANTIVIRUS AGENT; BETULIN; BETULONIC ACID 3 OXIME; BETULONIC ACID 3 OXIME ACETATE; BETULONIC ACID 3 OXIME HEMIPHTHALATE; BETULONIC ACID 3 OXIME HEMISUCCINATE; BETULONIC ACID 3 OXIME METHYLATE; BETULONIC ACID METHYLATE ACETATE; BETULONIC ACID METHYLATE HEMIPHTHALATE; BETULONIC ACID METHYLATE HEMISUCCINATE; INDOMETACIN; LIVER PROTECTIVE AGENT; TRITERPENOID; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SYNTHESIS; ECHO VIRUS; HERPES SIMPLEX VIRUS 1; INFLUENZA VIRUS A; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; RAT; STRUCTURE ACTIVITY RELATION;

EID: 3242770594     PISSN: 0091150X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAC.0000034305.96047.87     Document Type: Article

References (15)

1. S. Y. Ryu, S. U. Choi, C. O. Lee, et al., Arch. Pharm. Res., 17, 375 - 377 (1994).
2. G. Kweifio-Okai, B. Field, B. A. Rumble, et al., Drug Dev. Res., 35, 137 - 141 (1995).
3. Y. Kashiwada, J. Chiyo, Y. Ikeshiro, et al., Bioorg. Med Chem. Let., 11, 183 - 185 (2001).
4. Y. Kashiwada, J. Chiyo, Y. Ikeshiro, et al., Chem. Pharm. Bull., 48(9), 1387 - 1390 (2000).
5. O. B. Flekhter, L. T. Karachurina, L. R. Nigmatullina, et al., Bioorg. Khim., 28(6), 543 - 550 (2002).
6. J. S. Alves, J. C. M. de Castro, M. I. Freire, et al., Magn. Res. Chem., 38, 201 - 206 (2000).
7. O. B. Flekhter, L. T. Karachurina, V. V. Poroikov, et al., Bioorg. Khim., 26(3), 215 - 223 (2000).
8. O. B. Flekhter, L. R. Nigmatullina, L. A. Baltina, et al., Khim.-Farm. Zh., 36(9), 26 - 28 (2002).
9. O. B. Flekhter, L. R. Nigmatullina, L. T. Karachurina, et al., Khim.-Farm. Zh., 34(11), 17 - 20 (2000).
10. E. I. Boreko, N. I. Pavlova, G. V. Zaitseva, and I. A. Mikhailopulo, Vopr. Virusol., No. 5, 40 - 42 (2001).
11. T. V. Obolentseva, Ya. I. Khodzhai, and Yu. B. Lar'yanovskaya, Byull. Exp. Byul. Med., 77(3), 39 - 41 (1974).
12. S. V. Anichkov and I. S. Zavodskaya, Pharmacotherapy of Peptic Ulcers [in Russian], Meditsina, Leningrad (1965), pp. 27 - 30.
13. N. P. Skakun and S. F. Koval'chuk, Farmakol. Toksikol., 50(3), 97 - 99 (1987).
14. Kh. M. Nasyrov, L. S. Chepurina, and R. M. Kireeva, Eksp. Klin. Farmakol., 58(6), 60 - 63 (1995).
15. N. P. Skakun, A. N. Oleinik, and I. T. Pilyurin, Abstracts of Papers. All-Union Meeting "Bioantioxidant" [in Russian], Chernogolovka (1983), pp. 131 - 132.